Emendo Biotherapeutics vs Oriel Research
Emendo Biotherapeutics vs Oriel Research, compared side by side on 13 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Emendo Biotherapeutics is on 59/100 and Oriel Research on 12/100.
Where each one leads
Emendo Biotherapeutics
- our overall score: 59/100 against 12/100
- agent readiness: 40/100 against 22/100
- domain rating: 20/100 against 0/100
- headcount: 41 against 6
Oriel Research
Leads on none of the measures we hold for both companies.
At a glance
| Measure | Emendo Biotherapeutics | Oriel Research |
|---|---|---|
| What it is | Developing genetic medicines and cell therapies for severe diseases using proprietary CRISPR OMNI technology. | Crowdsourcing genomic data to discover disease markers and therapy correlations for personalized medicine. |
| Category | Healthcare, Genome Editing, CRISPR, Biotech | Healthcare, Genomics, HealthTech, Drug Discovery |
| Sells toBusiness model | B2B | B2C |
| Offering | Platform | Software |
| Founded | 2015 | 2017 |
| Headquarters | Tel Aviv, Israel | Not published |
| Status | Active | Inactive |
Size, funding and growth
| Measure | Emendo Biotherapeutics | Oriel Research |
|---|---|---|
| Employees | 41 | 6 |
| Headcount growthLast 12 months | -16.1% | Not published |
| Total funding | $61.0M | Not published |
| Latest round | Series B | Bootstrapped |
| LinkedIn followers | 5,333 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Emendo Biotherapeutics | Oriel Research |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 59/100 | 12/100 |
| Traction | 55/100 | 8/100 |
| Team | 40/100 | Not published |
| Search visibility | 44/100 | 9/100 |
| Quality | 68/100 | Not published |
| Agent readinessHow well an AI agent can read and act on the site | D (40/100) | F (22/100) |
| Domain ratingLink authority, 0-100 | 20/100 | 0/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Emendo Biotherapeutics | Oriel Research |
|---|---|---|
| Hosting | Google Cloud | Not detected |
| CMS | WordPress | Not detected |
| Frameworks | Bootstrap | Not detected |
| Analytics | Google Tag Manager | Not detected |
Emendo Biotherapeutics vs Oriel Research: common questions
Which is better, Emendo Biotherapeutics or Oriel Research?
On our 0-100 score Emendo Biotherapeutics rates higher (59/100 against 12/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 13 data points above: read the rows that match what you are buying for.
How do Emendo Biotherapeutics and Oriel Research compare on the numbers?
Emendo Biotherapeutics leads on our overall score (59/100 against 12/100), agent readiness (40/100 against 22/100), domain rating (20/100 against 0/100), headcount (41 against 6).
Read the full Emendo Biotherapeutics review and pricing or the Oriel Research review and pricing. You can also browse other Emendo Biotherapeutics alternatives we track.